Technology
EPAM Reports Results for Fourth Quarter and Full Year 2024
Published
2 years agoon
By
Fourth Quarter 2024
Revenues of $1.248 billion, up 7.9% year-over-yearGAAP Income from Operations was 10.9% of revenues and Non-GAAP Income from Operations was 16.7% of revenuesGAAP Diluted EPS of $1.80, an increase of 8.4%, and Non-GAAP Diluted EPS of $2.84, an increase of 3.3% on a year-over-year basis
Full Year 2024
Revenues of $4.728 billion, up 0.8% year-over-yearGAAP Income from Operations was 11.5% of revenues and Non-GAAP Income from Operations was 16.5% of revenuesGAAP Diluted EPS of $7.84, an increase of 11.0%, and Non-GAAP Diluted EPS of $10.86, an increase of 2.5% on a year-over-year basis
NEWTOWN, Pa., Feb. 20, 2025 /PRNewswire/ — EPAM Systems, Inc. (NYSE: EPAM), a leading digital transformation services and product engineering company, today announced results for its fourth quarter and full year ended December 31, 2024.
“After navigating a dynamic year, we are pleased to report a strong fourth quarter. We continued to build sequential momentum, and saw a return to year-over-year organic growth, while we simultaneously accelerated our global strategy with the acquisitions of NEORIS and First Derivative,” said Arkadiy Dobkin, CEO & President, EPAM. “As we look ahead, we believe 2025 will be a year of transition, as clients balance their cost focus with the need to accelerate their transformational and GenAI journeys. We see a strong need to continue to invest in our talent, advanced technological and consulting capabilities, and the integration of recent acquisitions to best position ourselves to capture market share once demand returns to more normalized levels.”
Fourth Quarter 2024 Highlights
Revenues increased to $1.248 billion, a year-over-year increase of $91.1 million, or 7.9%. On an organic constant currency basis, revenues grew 1.0% compared to the fourth quarter of 2023;GAAP income from operations was $136.5 million, an increase of $14.0 million, or 11.4%, compared to $122.5 million in the fourth quarter of 2023;Non-GAAP income from operations was $208.2 million, an increase of $7.8 million, or 3.9%, compared to $200.4 million in the fourth quarter of 2023;Diluted earnings per share (“EPS”) on a GAAP basis was $1.80, an increase of $0.14, or 8.4%, compared to $1.66 in the fourth quarter of 2023;Non-GAAP diluted EPS was $2.84, an increase of $0.09, or 3.3%, compared to $2.75 in the fourth quarter of 2023;Completed the acquisition of NEORIS creating a competitive offering for clients across Latin America and in Spanish- and Portuguese-speaking countries, while broadening EPAM’s global and nearshore delivery capabilities across Latin America and Europe; andCompleted the acquisition of First Derivative strengthening EPAM’s financial services consulting and delivery capabilities in North America, Europe and APAC and expanding our client portfolio in financial services.
Full Year 2024 Highlights
Revenues increased to $4.728 billion, a year-over-year increase of $37.4 million, or 0.8%. On an organic constant currency basis, revenues declined 1.7% year-over-year;We recorded a benefit of $68.8 million for research & development government incentives in Poland. Specifically, $23.5 million of the benefit related to activities performed during 2023 and $45.3 million of the benefit related to activities performed during the full year of 2024. This benefit was included as a reduction to our Cost of revenues. The impact of this benefit on net income was partially offset as the incentives drove a higher effective tax rate for both GAAP and non-GAAP results. We expect the incentive will be recurring with benefits recognized continuing in the future;GAAP income from operations was $544.6 million, an increase of $43.3 million, or 8.6%, compared to $501.2 million in 2023. GAAP income from operations benefited from the recognition of $68.8 million of incentives related to research and development activities performed in Poland and was negatively impacted by $31.3 million of costs incurred in connection with the Company’s Cost Optimization Programs;Non-GAAP income from operations was $779.2 million, an increase of $14.1 million, or 1.8%, compared to $765.1 million in 2023. Non-GAAP income from operations benefited from the recognition of $45.3 million of incentives related to research and development activities performed in Poland in 2024;Diluted EPS on a GAAP basis was $7.84, an increase of $0.78, or 11.0%, compared to $7.06 in 2023. EPS on a GAAP basis was positively impacted by the recognition of the Polish incentives, which increased income from operations. However, this benefit was partially offset by an increase to the effective tax rate; andNon-GAAP diluted EPS was $10.86, an increase of $0.27, or 2.5%, compared to $10.59 in 2023. EPS on a non-GAAP basis was positively impacted by the recognition of the Polish incentives for activities performed during the full year of 2024, which increased income from operations. However, this benefit was partially offset by an increase to the effective tax rate.
Cash Flow and Other Metrics
Cash provided by operating activities was $130.3 million in the fourth quarter of 2024, a decrease from $171.4 million in the fourth quarter of 2023; and was $559.2 million in 2024, a decrease from $562.6 million in 2023;The Company repurchased 53 thousand shares of its common stock for $13.0 million during the fourth quarter of 2024 under its share repurchase program. During the year ended December 31, 2024, the Company repurchased 1,854 thousand shares of its common stock for $398.0 million under its share repurchase programs. As of December 31, 2024, the Company had $437.0 million remaining under its share repurchase authorization;Cash, cash equivalents and restricted cash totaled $1.290 billion as of December 31, 2024, a decrease of $752.7 million, or 36.8%, from $2.043 billion as of December 31, 2023 largely the result of payments for the acquisitions of NEORIS and First Derivative; andTotal headcount was approximately 61,200 as of December 31, 2024. Included in this number were approximately 55,100 delivery professionals, an increase of 16.3% from December 31, 2023.
2025 Outlook – Full Year and First Quarter
Full Year
EPAM expects the following for the full year:
The Company expects the year-over-year revenue growth rate to be in the range of 10.0% to 14.0% for 2025. The Company expects the year-over-year revenue growth rate on an organic constant currency basis to be in the range of 1.0% to 5.0%;For the full year, EPAM expects GAAP income from operations to be in the range of 9.0% to 10.0% of revenues and non-GAAP income from operations to be in the range of 14.5% to 15.5% of revenues;The Company expects its GAAP effective tax rate and its non-GAAP effective tax rate to both be approximately 24.0%; andEPAM expects GAAP diluted EPS will be in the range of $6.78 to $7.08 for the year, and non-GAAP diluted EPS will be in the range of $10.45 to $10.75 for the year. The Company expects weighted average diluted shares outstanding for the year of 58.1 million.
First Quarter
EPAM expects the following for the first quarter:
The Company expects revenues will be in the range of $1.275 billion to $1.290 billion for the first quarter reflecting a year-over-year increase of 10.0% at the midpoint of the range. The Company expects year-over-year revenue growth on an organic constant currency basis to be approximately flat at the midpoint of the range;For the first quarter, EPAM expects GAAP income from operations to be in the range of 6.5% to 7.5% of revenues and non-GAAP income from operations to be in the range of 12.5% to 13.5% of revenues;The Company expects its GAAP effective tax rate to be approximately 19% and its non-GAAP effective tax rate to be approximately 24%; andEPAM expects GAAP diluted EPS will be in the range of $1.27 to $1.37 for the quarter, and non-GAAP diluted EPS will be in the range of $2.22 to $2.32 for the quarter. The Company expects weighted average diluted shares outstanding for the quarter of 57.7 million.
Conference Call Information
EPAM will host a conference call to discuss results on Thursday, February 20, 2025 at 8:00 a.m. EST. The conference call will be available live on the EPAM website at https://investors.epam.com. Please visit the website at least 15 minutes prior to the call to register for the event. For those who cannot access the live webcast, a replay will be available in the Investor Relations section of the website.
About EPAM Systems
Since 1993, EPAM Systems, Inc. (NYSE: EPAM) has used its software engineering expertise to become a leading global provider of digital engineering, cloud and AI-enabled transformation services, and a leading business and experience consulting partner for global enterprises and ambitious startups. We address our clients’ transformation challenges by focusing EPAM Continuum’s integrated strategy, experience and technology consulting with our 30+ years of engineering execution to speed our clients’ time to market and drive greater value from their innovations and digital investments.
We leverage AI and GenAI to deliver transformative solutions that accelerate our clients’ digital innovation and enhance their competitive edge. Through platforms like EPAM AI/RUN™ and initiatives like DIALX Lab, we integrate advanced AI technologies into tailored business strategies, driving significant industry impact and fostering continuous innovation.
We deliver globally but engage locally with our expert teams of consultants, architects, designers and engineers, making the future real for our clients, our partners, and our people around the world. We believe the right solutions are the ones that improve people’s lives and fuel competitive advantage for our clients across diverse industries. Our thinking comes to life in the experiences, products and platforms we design and bring to market.
Added to the S&P 500 and the Forbes Global 2000 in 2021 and recognized by Glassdoor and Newsweek as Most Loved Workplace, our multidisciplinary teams serve customers across six continents. We are proud to be among the top 15 companies in Information Technology Services in the Fortune 1000 and to be recognized as a leader in the IDC MarketScapes for Worldwide Experience Build Services, Worldwide Experience Design Services and Worldwide Software Engineering Services.
Learn more at www.epam.com follow us on LinkedIn.
Non-GAAP Financial Measures
EPAM supplements results reported in accordance with United States generally accepted accounting principles, referred to as GAAP, with non-GAAP financial measures. Management believes these measures help illustrate underlying trends in EPAM’s business and uses the measures to establish budgets and operational goals, communicate internally and externally, for managing EPAM’s business and evaluating its performance. Management also believes these measures help investors compare EPAM’s operating performance with its results in prior periods. EPAM anticipates that it will continue to report both GAAP and certain non-GAAP financial measures in its financial results, including non-GAAP results that exclude stock-based compensation expenses, acquisition-related costs including amortization of acquired intangible assets, impairment of assets, expenses associated with EPAM’s humanitarian commitment to its professionals in Ukraine, unbilled business continuity resources resulting from Russia’s invasion of Ukraine, costs associated with the geographic repositioning of EPAM employees based outside of Ukraine impacted by the war and geopolitical instability in the region, employee separation costs incurred in connection with restructuring programs including the Company’s exit from Russia, certain other one-time charges and benefits, changes in fair value of contingent consideration, foreign exchange gains and losses, excess tax benefits related to stock-based compensation, and the related effect on income taxes of the pre-tax adjustments. Management also compares revenues on an “organic constant currency basis,” which is a non-GAAP financial measure. This measure excludes the effect of acquisitions by removing revenues from an acquired company in the twelve months after completing an acquisition, the decision to exit from Russia by removing revenues from clients located in Russia in both the current period and prior period of comparison, and foreign currency exchange rate fluctuations by translating current period revenues into U.S. dollars at the weighted average exchange rates of the prior period of comparison. Because EPAM’s reported non-GAAP financial measures are not calculated in accordance with GAAP, these measures are not comparable to GAAP and may not be comparable to similarly described non-GAAP measures reported by other companies within EPAM’s industry. Consequently, EPAM’s non-GAAP financial measures should not be evaluated in isolation or supplant comparable GAAP measures, but rather, should be considered together with the information in EPAM’s consolidated financial statements, which are prepared in accordance with GAAP.
Forward-Looking Statements
This press release includes estimates and statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Our estimates and forward-looking statements are mainly based on our current expectations and estimates of future events and trends, which affect or may affect our business and operations. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. Those future events and trends may relate to, among other things, developments relating to the war in Ukraine and escalation of the war in the surrounding region, political and civil unrest or military action in the geographies where we conduct business and operate, difficult conditions in global capital markets, foreign exchange markets and the broader economy, and the effect that these events may have on customer demand and our revenues, operations, access to capital, and profitability. Other factors that could cause actual results to differ materially from those expressed or implied include general economic conditions, the risk factors discussed in the Company’s most recent Annual Report on Form 10-K and the factors discussed in the Company’s Quarterly Reports on Form 10-Q, particularly under the headings “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” and other filings with the Securities and Exchange Commission. Although we believe that these estimates and forward-looking statements are based upon reasonable assumptions, they are subject to several risks and uncertainties and are made based on information currently available to us. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.
EPAM SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share data)
Three Months Ended
December 31,
Year Ended December 31,
2024
2023
2024
2023
Revenues
$ 1,248,351
$ 1,157,257
$ 4,727,940
$ 4,690,540
Operating expenses:
Cost of revenues (exclusive of depreciation and amortization)
868,314
797,633
3,277,497
3,256,514
Selling, general and administrative expenses
216,969
213,972
816,300
815,065
Depreciation and amortization expense
26,556
23,158
89,559
91,800
Loss on sale of business
—
—
—
25,922
Income from operations
136,512
122,494
544,584
501,239
Interest and other income, net
6,451
13,962
46,876
51,124
Foreign exchange loss
(5,632)
(9,053)
(7,048)
(15,778)
Income before provision for income taxes
137,331
127,403
584,412
536,585
Provision for income taxes
34,032
29,849
129,879
119,502
Net income
$ 103,299
$ 97,554
$ 454,533
$ 417,083
Net income per share:
Basic
$ 1.82
$ 1.69
$ 7.93
$ 7.21
Diluted
$ 1.80
$ 1.66
$ 7.84
$ 7.06
Shares used in calculation of net income per share:
Basic
56,818
57,767
57,288
57,829
Diluted
57,435
58,913
57,983
59,085
EPAM SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except par value)
As of
December 31,
2024
As of
December 31,
2023
Assets
Current assets
Cash and cash equivalents
$ 1,286,267
$ 2,036,235
Trade receivables and contract assets, net of allowance of $5,612 and $11,864, respectively
1,002,175
897,032
Short-term investments
1,690
60,739
Prepaid and other current assets
136,116
97,355
Total current assets
2,426,248
3,091,361
Property and equipment, net
207,667
235,053
Operating lease right-of-use assets, net
128,244
134,898
Intangible assets, net
436,418
71,118
Goodwill
1,181,575
562,459
Deferred tax assets
269,799
197,901
Other noncurrent assets
100,522
59,575
Total assets
$ 4,750,473
$ 4,352,365
Liabilities
Current liabilities
Accounts payable
$ 44,702
$ 31,992
Accrued compensation and benefits expenses
484,952
412,747
Accrued expenses and other current liabilities
201,356
124,823
Income taxes payable, current
50,395
38,812
Operating lease liabilities, current
39,634
36,558
Total current liabilities
821,039
644,932
Long-term debt
25,194
26,126
Operating lease liabilities, noncurrent
98,426
109,261
Deferred tax liabilities, noncurrent
92,362
8,744
Other noncurrent liabilities
82,301
91,832
Total liabilities
1,119,322
880,895
Commitments and contingencies
Equity
Stockholders’ equity
Common stock, $0.001 par value; 160,000 authorized; 56,869 shares issued and outstanding at December 31, 2024, and 57,787 shares issued and outstanding at December 31, 2023
57
58
Additional paid-in capital
1,190,222
1,008,766
Retained earnings
2,555,796
2,501,107
Accumulated other comprehensive loss
(116,864)
(39,040)
Total EPAM Systems, Inc. stockholders’ equity
3,629,211
3,470,891
Noncontrolling interest in consolidated subsidiaries
1,940
579
Total equity
3,631,151
3,471,470
Total liabilities and equity
$ 4,750,473
$ 4,352,365
EPAM SYSTEMS, INC. AND SUBSIDIARIES
Reconciliations of Non-GAAP Financial Measures to Comparable GAAP Financial Measures
(Unaudited)
(In thousands, except percent and per share amounts)
Reconciliation of revenue growth as reported on a GAAP basis to revenue growth/(decline) on an organic constant currency basis is presented in the table below:
Three Months Ended
December 31, 2024
Year Ended
December 31, 2024
Revenue growth as reported
7.9 %
0.8 %
Foreign exchange rates impact
0.4 %
(0.1) %
Inorganic revenue growth
(7.3) %
(2.7) %
Impact of exit from Russia
— %
0.3 %
Revenue growth/(decline) on an organic constant currency basis
1.0 %
(1.7) %
Reconciliation of various income statement amounts from GAAP to non-GAAP for the three months and years ended December 31, 2024 and 2023:
Three Months Ended December 31, 2024
Year Ended December 31, 2024
GAAP
Adjustments
Non-GAAP
GAAP
Adjustments
Non-GAAP
Cost of revenues (exclusive of depreciation and amortization)(1)
$ 868,314
$ (22,040)
$ 846,274
$ 3,277,497
$ (59,821)
$ 3,217,676
Selling, general and administrative expenses(2)
$ 216,969
$ (37,637)
$ 179,332
$ 816,300
$ (145,329)
$ 670,971
Income from operations(3)
$ 136,512
$ 71,675
$ 208,187
$ 544,584
$ 234,625
$ 779,209
Operating margin
10.9 %
5.8 %
16.7 %
11.5 %
5.0 %
16.5 %
Net income(4)
$ 103,299
$ 60,066
$ 163,365
$ 454,533
$ 175,430
$ 629,963
Diluted earnings per share
$ 1.80
$ 2.84
$ 7.84
$ 10.86
Three Months Ended December 31, 2023
Year Ended December 31, 2023
GAAP
Adjustments
Non-GAAP
GAAP
Adjustments
Non-GAAP
Cost of revenues (exclusive of depreciation and amortization)(1)
$ 797,633
$ (22,183)
$ 775,450
$ 3,256,514
$ (89,464)
$ 3,167,050
Selling, general and administrative expenses(2)
$ 213,972
$ (49,747)
$ 164,225
$ 815,065
$ (125,768)
$ 689,297
Income from operations(3)
$ 122,494
$ 77,939
$ 200,433
$ 501,239
$ 263,871
$ 765,110
Operating margin
10.6 %
6.7 %
17.3 %
10.7 %
5.6 %
16.3 %
Net income(4)
$ 97,554
$ 64,211
$ 161,765
$ 417,083
$ 208,555
$ 625,638
Diluted earnings per share
$ 1.66
$ 2.75
$ 7.06
$ 10.59
Items (1) through (4) above are detailed in the following table with the specific cross-reference noted in the appropriate item.
Three Months Ended
December 31,
Year Ended
December 31,
2024
2023
2024
2023
Stock-based compensation expenses
$ 22,074
$ 19,228
$ 80,944
$ 68,797
Poland R&D incentives(a)
(556)
—
(23,473)
—
Humanitarian support in Ukraine(b)
522
2,955
2,350
11,252
Unbilled business continuity resources(c)
—
—
—
9,415
Total adjustments to GAAP cost of revenues(1)
22,040
22,183
59,821
89,464
Stock-based compensation expenses
22,624
18,966
86,353
78,933
Cost Optimization charges(d)
4,837
27,936
31,270
35,052
Other acquisition-related expenses
7,031
275
15,808
2,723
Humanitarian support in Ukraine(b)
3,127
836
10,821
6,145
Geographic repositioning(e)
(4)
916
849
1,793
One-time charges
22
818
228
1,122
Total adjustments to GAAP selling, general and administrative expenses(2)
37,637
49,747
145,329
125,768
Amortization of purchased intangible assets
11,998
6,009
29,475
22,717
Loss on sale of business(f)
—
—
—
25,922
Total adjustments to GAAP income from operations(3)
71,675
77,939
234,625
263,871
Foreign exchange loss
5,632
9,053
7,048
15,778
Change in fair value of contingent consideration included in Interest and other income, net
1,673
1,000
5,700
2,818
One-time benefits/(charges) included in Interest and other income, net
(1,331)
700
(3,143)
700
Provision for income taxes:
Tax effect on non-GAAP adjustments
(15,640)
(19,755)
(44,522)
(53,815)
Excess tax benefits related to stock-based compensation
(1,943)
(4,726)
(22,448)
(19,829)
Net discrete benefit from tax planning(g)
—
—
(1,830)
(968)
Total adjustments to GAAP net income(4)
$ 60,066
$ 64,211
$ 175,430
$ 208,555
(a)
We have excluded from non-GAAP results the portion of the benefit from Poland R&D incentives related to qualifying activities performed in 2023 as it represents a nonrecurring one-time benefit.
(b)
Humanitarian support in Ukraine includes expenses related to EPAM’s $100 million humanitarian commitment in response to Russia’s invasion of Ukraine to support EPAM professionals and their families in and displaced from Ukraine. These expenses are incremental to those expenses incurred prior to the crisis, clearly separable from normal operations, and not expected to recur once the crisis has subsided and operations return to normal.
(c)
Given the uncertainty in the region introduced by Russia’s invasion of Ukraine, EPAM has assigned delivery professionals in locations outside of the region to ensure the continuity of delivery for customers who have substantial delivery exposure to Ukraine or other delivery concerns resulting from the invasion. These employees are not billed to clients and operate largely in a standby or backup capacity. These expenses are incremental to those expenses incurred prior to the crisis, clearly separable from normal operations, and not expected to recur once the crisis has subsided and operations return to normal.
(d)
Cost Optimization charges include severance, facilities and contract termination charges incurred in connection with the programs initiated in the third quarter of 2023 and second quarter of 2024. Consistent with the Company’s historical non-GAAP policy, costs incurred in connection with formal restructuring initiatives have been excluded from non-GAAP results as these are one-time and unusual in nature.
(e)
Geographic repositioning includes expenses associated with the relocation to other countries of employees based outside of Ukraine impacted by the war and geopolitical instability in the region, and includes the cost of accommodations, travel and food. These expenses are incremental to those expenses incurred prior to the crisis, clearly separable from normal operations, and not expected to recur once the crisis has subsided and operations return to normal.
(f)
On July 26, 2023, the Company completed the sale of its remaining operations in Russia and recorded a loss on sale of approximately $25.9 million during the year ended December 31, 2023, including the recognition of the accumulated currency translation loss related to this foreign entity that was previously included in Accumulated other comprehensive loss in the financial statements. The Company excluded this loss from non-GAAP results as it is one-time and unusual in nature.
(g)
One-time benefit related to the implementation of tax planning to disregard certain foreign subsidiaries as separate entities for U.S. income tax purposes. Consistent with the Company’s historical non-GAAP policy, the benefit related to the implementation of tax planning has been excluded from non-GAAP results as it is one-time and unusual in nature.
EPAM SYSTEMS, INC. AND SUBSIDIARIES
Reconciliations of Guidance Non-GAAP Financial Measures to Comparable GAAP Financial Measures
(Unaudited)
The below guidance constitutes forward-looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. Actual results may differ materially from the Company’s expectations depending on factors discussed in the Company’s filings with the Securities and Exchange Commission.
Reconciliation of expected revenue growth on a GAAP basis to expected revenue growth on an organic constant currency basis is presented in the table below:
First Quarter 2025
Full Year 2025
(at midpoint of
range)
Revenue growth
10.0 %
10.0% to 14.0%
Foreign exchange rates impact
1.4 %
0.9 %
Inorganic revenue growth
(11.4) %
(9.9) %
Revenue growth on an organic constant currency basis
— %
1.0% to 5.0%
Reconciliation of expected GAAP to non-GAAP income from operations as a percentage of revenues is presented in the table below:
First Quarter 2025
Full Year 2025
GAAP income from operations as a percentage of revenues
6.5% to 7.5%
9.0% to 10.0%
Stock-based compensation expenses
3.9 %
3.7 %
Included in cost of revenues (exclusive of depreciation and amortization)
1.9 %
1.8 %
Included in selling, general and administrative expenses
2.0 %
1.9 %
Humanitarian support in Ukraine(b)
0.2 %
0.3 %
Cost Optimization charges(d)
0.5 %
0.2 %
Amortization of acquired intangible assets
1.4 %
1.3 %
Non-GAAP income from operations as a percentage of revenues(h)
12.5% to 13.5%
14.5% to 15.5%
(h) EPAM has not included the impact of potential future One-time charges including asset impairments, unusual gains and losses, expenses incurred in connection with future cost optimization actions, and Other acquisition-related expenses because the Company is unable to predict these amounts with reasonable certainty.
Reconciliation of expected GAAP to non-GAAP effective tax rate is presented in the table below:
First Quarter 2025
Full Year 2025
GAAP effective tax rate (approximately)
19 %
24 %
Excess tax benefits related to stock-based compensation
7.5 %
2.6 %
Tax effect on non-GAAP adjustments
(2.5) %
(2.6) %
Non-GAAP effective tax rate (approximately)
24 %
24 %
Reconciliation of expected GAAP to non-GAAP diluted earnings per share is presented in the table below:
First Quarter 2025
Full Year 2025
GAAP diluted earnings per share
$1.27 to $1.37
$6.78 to $7.08
Stock-based compensation expenses
0.87
3.33
Included in cost of revenues (exclusive of depreciation and amortization)
0.42
1.61
Included in selling, general and administrative expenses
0.45
1.72
Humanitarian support in Ukraine(b)
0.07
0.25
Cost Optimization charges(d)
0.10
0.12
Amortization of acquired intangible assets
0.31
1.17
Foreign exchange loss
0.02
0.07
Provision for income taxes:
Tax effect on non-GAAP adjustments
(0.29)
(1.04)
Excess tax benefits related to stock-based compensation
(0.13)
(0.23)
Non-GAAP diluted earnings per share(h)
$2.22 to $2.32
$10.45 to $10.75
View original content to download multimedia:https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2024-302381106.html
SOURCE EPAM Systems, Inc.
You may like
Technology
Revolune and Concept Life Sciences Partner to Help Customers Transition Multiplex IF Assays to Flexible New Workflows
Published
8 minutes agoon
October 27, 2026By
OBERKOCHEN, Germany, Oct. 27, 2026 /PRNewswire/ — Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and scale multiplex immunofluorescence assays using Revolune’s flexible staining technology, which now supports 4- to 7-plex assays.
The collaboration addresses a growing market need as customers evaluate alternatives to existing workflows and reconsider how best to support tissue biomarker research. With Revolune now offering 4- to 7-plex assay capabilities, Concept Life Sciences can help customers transfer established assays onto the Revolune platform, preserve valuable panel know-how, and move more easily from existing workflows to flexible, ready-to-use multiplex formats.
“Many customers are not starting from a blank page — they already have assays, panels, and tissue biomarker strategies they need to preserve while moving toward more flexible workflows,” said Adrian Arechiga, CCO of Revolune. “Concept Life Sciences brings the translational biology, biomarker, and assay development expertise needed to help customers make that transition practically and confidently.”
Concept Life Sciences is a leading contract research organization serving the global life sciences industry, with capabilities across discovery, development, analytical services, translational biology, biomarker discovery, spatial biology, and end-to-end chemistry. By combining these capabilities with Revolune’s adaptable multiplex immunofluorescence technology, the companies aim to help customers generate decision-ready tissue biomarker insights while reducing the operational burden of assay transfer and implementation.
The partnership is designed for research teams that want to retain the scientific value of existing workflows while gaining access to a more flexible platform for multiplex staining. Customers can work with Concept Life Sciences to evaluate assay transfer feasibility, optimize panel design, run tissue staining workflows, and connect resulting biomarker data to broader discovery and development programs.
“We are excited to work with Revolune to support customers who are rethinking how they approach multiplex tissue analysis,” said Adam Davenport, CSO at Concept Life Sciences. “Together, we can help teams transfer existing assays, explore new panels, and apply multiplex immunofluorescence in ways that support meaningful translational decisions.”
The Concept Life Sciences partnership forms part of Revolune’s broader strategy to build an ecosystem of partners that support adoption across different customer needs — from specialist service execution to assay migration, translational biology, and integrated R&D support.
Meet Revolune and Concept Life Sciences at SITC 2026
Revolune and Concept Life Sciences will both be attending the Society for Immunotherapy of Cancer (SITC) Annual Meeting, November 4–8, 2026, in Phoenix, Arizona.
Meet both teams at SITC at Sundown, a relaxed evening of complimentary drinks, dinner and conversation hosted by Concept Life Sciences on November 6, 6.30-8.30 pm. More information: https://www.conceptlifesciences.com/campaigns/sitc-2026.
About Revolune
Revolune is a life science company dedicated to making multiplex immunofluorescence as accessible and practical as routine tissue analysis. Its reagent technologies help laboratories move rapidly from existing primary antibodies to ready-to-use multiplex kits, simplifying spatial biology workflows and enabling researchers to focus on biological questions rather than assay management.
About Concept Life Sciences
Concept Life Sciences is a leading contract research organisation (CRO) serving the global life sciences industry. For over 25 years, the company, and its heritage companies, have provided consultative and collaborative drug discovery and development services. Our approach, supported by passionate scientists and world-leading capabilities, enables clients to overcome complex scientific challenges and improves program success rates. The company has successfully helped 29 candidates advance to the clinic.
The company offers sophisticated translational biology services coupled with exceptional end-to-end chemistry capabilities to support drug discovery and development across a range of established and emerging modalities, with the ability to seamlessly integrate capabilities and provide bespoke solutions to address client needs.
Collectively, the company’s high-quality services and commitment to customer service across the drug development pathway enhances efficiency in drug discovery, helping clients advance their drugs to clinic in as little as 32 months, well ahead of the industry average of 60 months.
View original content to download multimedia:https://www.prnewswire.com/news-releases/revolune-and-concept-life-sciences-partner-to-help-customers-transition-multiplex-if-assays-to-flexible-new-workflows-302919466.html
SOURCE Revolune
Technology
From Global Orders to Global Growth: Financial Infrastructure for Mid-Market Exporters
Published
8 minutes agoon
October 27, 2026By
At the 140th Canton Fair, PhotonPay demonstrates how its stablecoin-centric financial operating system helps growing exporters manage cross-border collections, currency conversion and global payments.
HONG KONG, Oct. 27, 2026 /PRNewswire/ — For a growing homewares exporter, a major overseas order brings opportunity, but also an immediate question: how will the business finance production, cover shipping costs and manage cash until the buyer pays?
A furniture manufacturer may need to pay suppliers weeks or months before receiving the final payment. A home décor or festive-goods exporter may be managing several seasonal orders at once, each with different delivery schedules, payment terms and currencies. As the business expands into more markets, tracking incoming payments, converting currencies and paying suppliers becomes increasingly complex.
These are everyday challenges behind international trade. At the second phase of the 140th Canton Fair, themed “Quality Home Life” and featuring furniture, kitchenware, household items, home decorations, gifts and festive products, PhotonPay is highlighting how financial infrastructure can help growing exporters manage these demands as they expand internationally.
Financial Tools for the Next Stage of Growth
Large multinational companies can draw on dedicated treasury teams, established banking relationships and sophisticated systems to manage funds across markets. Smaller businesses may have simpler payment needs. Mid-market exporters occupy a different position: their operations span multiple countries and currencies, while their finance teams often remain lean.
At the same time, production and freight costs must be covered before all customer payments arrive. Receivables may be spread across currencies and accounts, while suppliers expect payment according to their own schedules. Finance teams must track receipts, reconcile invoices and maintain a clear view of available funds.
Across multiple markets and overlapping orders, these tasks can consume significant time and complicate decisions about when and where to deploy cash. Growing exporters need practical tools to coordinate collections, manage funds across currencies and pay counterparties worldwide, without having to build a large treasury function from scratch.
Connecting Fiat and Stablecoin Rails to Global Business
Bank accounts and fiat payment networks remain central to international trade, connecting businesses to local collection methods and established banking relationships. Stablecoins offer an additional way to transfer value across borders, with transactions possible outside conventional banking hours depending on the network and transaction arrangements.
Connecting fiat and stablecoin rails can give businesses more flexibility in managing cross-border funds. For exporters, the practical value lies in connecting the stages of a cross-border financial workflow: receiving customer payments, converting currencies and making funds available for supplier payments and other business expenses.
PhotonPay is built around this connection. As a stablecoin-centric financial operating system, PhotonPay brings together a cross-border financial infrastructure across both fiat and stablecoin rails.
Its multi-asset wallet supports fiat currencies and stablecoins within a unified environment. Local collection capabilities cover 21 currencies, enabling businesses to receive payments in the currencies their customers use. Through integrated on- and off-ramp services, businesses can convert between fiat and stablecoins, while 24/7 foreign exchange allow funds to move across markets at any time. Cross-border payouts in fiat and stablecoins are available across 200+ countries and territories. Card issuing capabilities also allow companies to manage overseas business spending directly from one platform.
These capabilities connect the key stages of cross-border financial operations, and for growing exporters, this provides a more integrated way to manage international payments as their business expands.
PhotonPay also extends its infrastructure to platforms through Embedded Finance. Its APIs enable B2B platforms, marketplaces and other digital businesses to integrate financial capabilities, including accounts, fiat and stablecoin wallets, global payouts and card issuing, into their own products. This allows platforms to build collection, payment and fund management services into existing workflows and extend financial capabilities to their customers.
Financial Infrastructure That Grows With the Business
For mid-market exporters, international growth brings new customers, more markets and greater demands on financial operations. The ability to manage funds across borders needs to keep pace, supporting everything from the next production run to the next supplier payment and the next market entry.
By connecting fiat and stablecoin rails within one financial operating system, PhotonPay helps growing businesses manage cross-border funds with greater flexibility as they scale internationally.
Visit PhotonPay at Area D, Booths DT1714–DT1718, during the 140th Canton Fair.
About PhotonPay
PhotonPay is a stablecoin-powered payment operating system built for global infrastructure. Designed for modern enterprises, PhotonPay enables businesses to send, receive, convert, and settle funds across both fiat and stablecoin rails through a single, compliance-first integration, spanning 200+ countries and territories.
For more information, visit [www.photonpay.com].
Disclaimer
This material is for general informational purposes only and does not constitute legal, regulatory, tax, accounting, or investment advice, nor an offer or solicitation for any product or service. The availability, features, and regulatory treatment of PhotonPay’s products and services may vary depending on the user’s location, business model, and the laws and regulations that apply. Any descriptions of functionality, performance, efficiency, cost savings, or compliance support (including, without limitation, references to “real‑time”, “24/7”, “high‑efficiency”, or “compliant” solutions) are aspirational or forward‑looking in nature. Actual outcomes may differ due to market conditions, technological constraints, and regulatory developments, and PhotonPay makes no express or implied representation, warranty, or guarantee as to the achievement of any particular result.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/from-global-orders-to-global-growth-financial-infrastructure-for-mid-market-exporters-302920151.html
SOURCE PhotonPay
Technology
Rockwell Automation Unveils Record-Breaking Innovation Lineup at Automation Fair 2026
Published
8 minutes agoon
October 27, 2026By
From AI-powered manufacturing and next-generation control to cybersecurity and digital engineering, Rockwell showcases technologies designed to help manufacturers build the future of industrial operations
MILWAUKEE, Oct. 27, 2026 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced an expanded product showcase for Automation Fair® 2026. Across the plant floor and enterprise, Rockwell’s latest innovations help manufacturers unlock greater productivity, simplify operations and strengthen resilience in an increasingly complex industrial environment. Together, these technologies demonstrate how AI, automation and digital transformation are reshaping the future of industrial operations.
At Automation Fair 2026, attendees will get an exclusive look at new technologies designed to help manufacturers modernize production, accelerate decision-making and scale innovation with greater confidence. The innovations span Rockwell’s automation and software portfolio showcasing practical applications that address some of the industry’s most pressing operational challenges.
“Production systems today are balancing growth, workforce challenges, cybersecurity threats and the need to adapt faster than ever before,” said Matheus Bulho, senior vice president, software & control, Rockwell Automation. “At Automation Fair 2026, we’re bringing together hardware, software and industrial intelligence in new ways, giving customers the tools to move faster, adapt with confidence and create more resilient and autonomous operations.”
Among the list of record-breaking innovative new technologies being showcased are:
LogixEdge™ Controller, enhancing the power of Logix with new form factors and seamless integration of IT and OT workloads that further amplify Logix’s powerful multidiscipline control and information capabilities, including AI workloads that enable autonomous controlCompactLogix® 5390 Controller, delivering enhanced performance and security with greater scalability for modern production system environments.PointMax™ I/O, a next-generation I/O platform designed to simplify deployment and support high-performance machine applications.Armor™ PowerFlex® 330 Integrated Drive Motor, combining motor and drive functionality in a compact solution to reduce complexity and accelerate installation.EtherNet/IP™ In-cabinet Solution, helping manufacturers simplify what it takes to construct, wire, deploy and manage industrial control systems more efficiently.FactoryTalk® Optix™ Version 1.9 and new OptixPanel™ Pro and PanelView™ Pro graphic terminals, providing expanded visualization capabilities across larger distributed systems, enhanced security and a modern operator experience.FactoryTalk® Conductor™, enabling organizations to orchestrate industrial intelligence and agentic engineering across design, operations and maintenance for their entire operations.FactoryTalk® AssetIQ™, FactoryTalk® Design Workbench™ and FactoryTalk® ResilientEdge™ software, helping customers simplify enterprise OT asset management, streamline engineering and improve resilience of edge deployments.New AI innovations for the Plex Smart Manufacturing Platform™ and AI-powered Quality Management capabilities, bringing practical artificial intelligence to everyday manufacturing workflows.Expanded cybersecurity offerings, including SecureOT™ Platform Managed Services, OT Cybersecurity Assessment Suite, and capabilities designed to support OEMs in building more secure machines from the start
In addition to product announcements, attendees will have the opportunity to experience live demonstrations, engage with Rockwell Automation experts and partners and explore the innovations driving greater productivity, flexibility and resilience across manufacturing.
Registration is now open. Join thousands of industrial professionals at Automation Fair 2026 and be among the first to experience Rockwell’s latest innovations in action. Register today at automationfair.com.
About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 26,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-automation-unveils-record-breaking-innovation-lineup-at-automation-fair-2026-302907266.html
SOURCE Rockwell Automation, Inc.
Revolune and Concept Life Sciences Partner to Help Customers Transition Multiplex IF Assays to Flexible New Workflows
From Global Orders to Global Growth: Financial Infrastructure for Mid-Market Exporters
Rockwell Automation Unveils Record-Breaking Innovation Lineup at Automation Fair 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoMiami Startup BOB Raises $5.5M To Build An AI-Powered Banking Platform
-
Coin Market4 days agoBitcoin ETFs bleed $635M as October slides back into the red
-
Coin Market4 days agoCysic dangles a 10% bounty, hacker pours loot into Tornado Cash
-
Coin Market4 days agoEthereum delays Glamsterdam Hoodi testnet launch over security risks
-
Coin Market4 days agoMalaysia, Thailand join Singapore’s cross-border stablecoin push
-
Technology4 days agoKin Becomes First U.S. Home Insurer to Enable WebMCP for AI Shopping
-
Coin Market5 days agoWinklevoss PAC moves into Texas Senate race with $81K ad buy
-
Technology5 days agoLunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister
